New scalp injection trial aims to regrow hair in alopecia areata
NCT ID NCT06826196
Summary
This is an early-stage study to see if a new injectable solution called ALD-102 is safe and can help regrow hair in people with alopecia areata. Researchers will give small injections into the scalp every four weeks for two months and compare the results to untreated or placebo-treated spots. The study will enroll 24 adults to check for side effects and see if the treatment shows any early signs of helping hair grow back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA (AA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre de Recherche Saint-Louis
RECRUITINGQuébec, Quebec, QC G1W 4R4, Canada
-
Clinical Trial Research Institute
RECRUITINGThousand Oaks, California, 91320, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dermatology Specialists of Spokane
RECRUITINGSpokane, Washington, 99202, United States
-
Innovaderm
RECRUITINGMontreal, Quebec, H2X 2V1, Canada
-
Options Research Group
RECRUITINGWest Lafayette, Indiana, 47906, United States
-
The Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Centre for Clinical Trials
RECRUITINGOakville, Ontario, L6J 7W5, Canada
Conditions
Explore the condition pages connected to this study.